Lobbying Relationship

Client

Alliance for Cell Therapy Now

More records

Lobbying firm

ANDREW VOGT STRATEGIES LLC

More records

  • Increased funding for research on regenerative medicine and cell-based therapies at the National Institutes of Health and Department of Health and Human Services; implementation of the 21st Century Cures Act; regulation of regenerative medicine and cell therapies.
  • Increased funding for research on regenerative medicine and cell therapies at the National Institutes of Health and Department of Health and Human Services; Implementation of the 21st Century Cures Act

Duration: to

General Issues: Health Issues, Budget/Appropriations

Spending: about $120,000 (But it's complicated. Here's why.)

Agencies lobbied since 2021: U.S. Senate, House of Representatives, Natl Institutes of Health (NIH), Food & Drug Administration (FDA)

Bills mentioned

H.R.941: TRANSPLANT Act of 2021

Sponsor: Doris Matsui (D-Calif.)

S.288: TRANSPLANT Act of 2021

Sponsor: Jack Reed (D-R.I.)

Show All Mentioned Bills

Lobbyists

Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.

Lobbyist Covered positions?
Andrew Vogt Health Professional Staff, Senate Committee on Health, Education, Labor, and Pensions: January 2017 - April 2021 Legislative Assistant/Aide/Correspondent, Staff Assistant, Senator Mark Kirk: May 2014 - December 2016 Health Professional Staff, Senate Health, Education, Labor, and Pensions Committee; Legislative Assistant, Sen. Mark Kirk Health Professional Staff for U.S. Senate Committee on Health, Education, Labor and Pensions, Legislative Assistant for U.S. Senator Mark Kirk

Disclosures Filed

Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.

Termination
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Registration

Source: Clerk of the U.S. House of Representatives and Secretary of the Senate

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page